According to the Zhitong Finance App, Guoyi Company (688828.SH) issued an initial public offering of shares and a prospectus for listing on the Science and Technology Innovation Board. The current public offering of 4 million shares accounts for about 10% of the total share capital after issuance. The initial number of strategic placements issued in this offering was 8.02 million shares, accounting for 20.00% of the current offering. The final strategic placement ratio and amount will be determined after T-2 determines the issuance price. The difference between the final strategic placement quantity and the initial strategic placement quantity will be reimbursed according to the principles stipulated in the callback mechanism. The subscription date is July 31, 2026.
Since its establishment, the issuer has focused on the research and development of high-end scientific instruments, providing universities, research institutes, and enterprises around the world with high-end scientific instruments and equipment for cutting-edge exploration in various fields such as quantum technology, materials science, chemistry, biomedicine, and advanced manufacturing, and actively contributing to solving the problem of import dependency in related fields. During the reporting period, the main business revenue was 38,9564 million yuan, 483.7542 million yuan, and 662.6571 million yuan, respectively. The compound revenue growth rate in the past three years was close to 30%, forming business segments such as quantum information technology, spin resonance, electron microscopy, drill-in measurement, and gas adsorption analysis.
From January to March 2026, the company's revenue was 52.672 million yuan, a slight decrease over the previous year. From January to March 2026, the company's total profit, net profit attributable to owners of the parent company, and net profit attributable to owners of the parent company increased compared to the same period of the previous year. The main factors were: on the one hand, with the expansion of the business scale, the company expanded its domestic and overseas sales team, which increased employee remuneration; on the other hand, the company added some new instrument R&D projects, expanded the size of the R&D team, and the salary and material costs of R&D employees all increased year-on-year.
The funds raised this time are mainly used to invest in the following projects: high-end scientific instrument industrialization projects, quantum technology development research institutes construction projects, and application center network construction projects. It is proposed to invest 1,169 billion yuan in raised capital.